Efficacy of dendritic cells matured early with OK-432 (Picibanil®), prostaglandin E2, and interferon-α as a vaccine for a hormone refractory prostate cancer cell line

Journal of Korean Medical Science

Volumn 25, Issue 9, 2010, Pages 1284-1290

  Yoo, Changhee ^a   Do, Hyun Ah ^b   Jeong, In Gab ^b   Park, Hongzoo ^c   Hwang, Jung Jin ^b   Hong, Jun Hyuk ^b   Cho, Jin Seon ^a   Choo, Myong Soo ^b   Ahn, Hanjong ^b   Kim, Choung Soo ^b  

^a Hallym University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

Cancer vaccines; Dendritic cells; Immunotherapy; Prostatic neoplasms

Indexed keywords

ALPHA INTERFERON; CANCER VACCINE; IMMUNOLOGIC FACTOR; LIPOPOLYSACCHARIDE; PICIBANIL; PROSTAGLANDIN E2;

ARTICLE; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFECT; HUMAN; IMMUNOLOGY; MALE; NEOPLASM; PHENOTYPE; PROSTATE TUMOR; TUMOR CELL LINE;

CANCER VACCINES; CELL LINE, TUMOR; DENDRITIC CELLS; DINOPROSTONE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; LIPOPOLYSACCHARIDES; MALE; NEOPLASMS, HORMONE-DEPENDENT; PHENOTYPE; PICIBANIL; PROSTATIC NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77956532068     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.9.1284     Document Type: Article

References (21)

1. Schuler G, Steinman RM. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med 1997; 186: 1183-7.
2. Koido S, Hara E, Homma S, Torii A, Mitsunaga M, Yanagisawa S, Toyama Y, Kawahara H, Watanabe M, Yoshida S, Kobayashi S, Yanaga K, Fujise K, Tajiri H. Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells. J Immunol 2007; 178: 613-22.
3. Sakakibara M, Kanto T, Inoue M, Kaimori A, Yakushijin T, Miyatake H, Itose I, Miyazaki M, Kuzushita N, Hiramatsu N, Takehara T, Kasahara A, Hayashi N. Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-α as potent immune enhancers. J Immunother 2006; 29: 67-77.
4. Koido S, Hara E, Homma S, Mitsunaga M, Takahara A, Nagasaki E, Kawahara H, Watanabe M, Toyama Y, Yanagisawa S, Kobayashi S, Yanaga K, Fujise K, Gong J, Tajiri H. Synergistic induction of antigen-specific CTL by fusion of TLR-stimulated dendritic cells and heat stressed tumor cells. J Immunol 2007; 179: 4874-83.
5. Shu YQ, Gu Y. The effect of dendritic cells activated by OK-432 and pulsed with antigens on cytokine induced killers. Biomed Pharmacother 2006; 60: 156-60.
6. Draube A, Beyer M, Schumer S, Thomas RK, von Tresckow B, Koslowsky TC, Krieglstein CF, Schultze JL, Wolf J. Efficent activation of autologous tumor-specific T cells: a simple coculture technique of autologous dendritic cells compared to established cell fusion strategies in primary human colorectal carcinoma. J Immunother 2007; 30: 359-69.
7. Larmonier N, Merino D, Nicolas A, Cathelin D, Benson A, Bateman A, Solary E, Martin F, Katsanis E, Bonnotte B. Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading. Apoptosis 2006; 11: 1513-24.
8. Shimizu K, Kuriyama H, Kjaergaard J, Lee W, Tanaka H, Shu S. Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotheraphy. J Immunother 2004; 27: 265-72.
9. Kao JY, Zhang M, Chen CM, Chen JJ. Superior efficacy of dendritic celltumor fusion vaccine compared with tumor lysate-pulsed dendritic cell vaccine in colon cancer. Immunol Lett 2005; 101: 154-9.
10. Lundqvist A, Palmborg A, Bidla G, Whelan M, Pundha H, Pisa P. Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses. Med Oncol 2004; 21: 155-65.
11. Tanaka F, Yamaguchi H, Haraguchi N, Mashino K, Ohta M, Inoue H, Mori M. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes. Int J Oncol 2006; 29: 1263-8.
12. Moldenhauer A, Nociari MM, Dias S, Lalezari P, Moore MA. Optimized culture conditions for the generation of dendritic cells from peripheral blood monocytes. Vox Sang 2003; 84: 228-36.
13. Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, Goldman M. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol 1997; 158: 2919-25.
14. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J. Activation of human dendritic cells through CD40 crosslinking. J Exp Med 1994; 180: 1263-72.
15. Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 1998; 161: 3042-9.
16. Aiba S, Terunuma A, Manome H, Tagami H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol 1997; 27: 3031-8.
17. Kaisho T, Akira S. Toll-like receptors and their signaling mechanism in innate immunity. Acta Odontol Scand 2001; 59: 124-30.
18. Itoh T, Ueda Y, Okugawa K, Fujiwara H, Fuji N, Yamashita T, Fujiki H, Harada S, Yoshimura T, Yamagishi H. Streptococcal preparation OK432 promotes functional maturation of human monocyte-derived dendritic cells. Cancer Immunol Immunother 2003; 52: 207-14.
19. Toyokawa H, Inaba M, Takai S, Satoi S, Beuth J, Ko HL, Matsui Y, Kwon AH, Kamiyama Y, Ikehara S. Enhancement of circulating dendritic cell activity by immunomodulators (OK432 and KP-40). Anti-cancer Res 2002; 22: 2137-45.
20. Kim KW, Kim SH, Shin JG, Kim GS, Son YO, Park SW, Kwon BH, Kim DW, Lee CH, Sol MY, Jeong MH, Chung BS, Kang CD. Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity. Int J Cancer 2004; 109: 685-90.
21. Koido S, Hara E, Homma S, Mitsunaga M, Takahara A, Nagasaki E, Kawahara H, Watanabe M, Toyama Y, Yanagisawa S, Kobayashi S, Yanaga K, Fujise K, Gong J, Tajiri H. Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells. J Immunol 2007; 179: 4874-83.